Literature DB >> 17383308

Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease.

Dhrubo J Rakhit1, Xiaohong H Zhang, Rodel Leano, Kirsten A Armstrong, Nicole M Isbel, Thomas H Marwick.   

Abstract

OBJECTIVE: The outcome of patients with chronic kidney disease (CKD) is influenced by overt left ventricular (LV) abnormalities. We sought the predictive value and treatment response of subclinical LV dysfunction in CKD.
METHOD: Resting and dobutamine stress echocardiography were used to identify LV enlargement, dysfunction, or ischemia in 176 patients with CKD. In 129 patients who had normal dobutamine stress echocardiography, myocardial tissue characterization was performed using tissue Doppler imaging and integrated backscatter. Clinical, biochemical, and echocardiographic parameters were recorded at baseline, and patients were followed up for cardiac events and all-cause mortality over 2.4 years. Follow-up echocardiographic and tissue characterization parameters were performed in 80 patients.
RESULTS: Previous cardiac history (HR 5.2, P = .002) and serum phosphate (HR 6.2, P = .001) were independent clinical predictors of events (model chi2 = 20.9). Diastolic tissue velocity (HR 0.8, P = .05) was an independent predictor of outcome, and its addition to clinical assessment added incremental prognostic information (model chi2 = 24.8, P < .001). Patients who underwent transplantation (n = 45) showed reduction of wall thickness (P < .001) and LV volumes (P < .001) and increases in diastolic tissue velocity (P = .007) and strain (P = .001), whereas these measurements worsened in those who remained on dialysis.
CONCLUSION: In patients with CKD, subclinical LV dysfunction is associated with adverse outcome. Subclinical disease can be improved by transplantation but progresses in patients who continue on dialysis.

Entities:  

Mesh:

Year:  2007        PMID: 17383308     DOI: 10.1016/j.ahj.2007.01.028

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

1.  Restoration of renal function does not correct impairment of uremic HDL properties.

Authors:  Chantal Kopecky; Michael Haidinger; Ruth Birner-Grünberger; Barbara Darnhofer; Christopher C Kaltenecker; Gunther Marsche; Michael Holzer; Thomas Weichhart; Marlies Antlanger; Johannes J Kovarik; Johannes Werzowa; Manfred Hecking; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

2.  Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.

Authors:  Rafael Kramann; Johanna Erpenbeck; Rebekka K Schneider; Anna B Röhl; Marc Hein; Vincent M Brandenburg; Merel van Diepen; Friedo Dekker; Nicolaus Marx; Jürgen Floege; Michael Becker; Georg Schlieper
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

3.  Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Manvir K Hayer; Ashwin Radhakrishnan; Anna M Price; Boyang Liu; Shanat Baig; Christopher J Weston; Luca Biasiolli; Charles J Ferro; Jonathan N Townend; Richard P Steeds; Nicola C Edwards
Journal:  JACC Cardiovasc Imaging       Date:  2020-07-15

4.  Predictive value of echocardiographic parameters for clinical events in patients starting hemodialysis.

Authors:  Seung Seok Han; Goo-Yeong Cho; Youn Su Park; Seon Ha Baek; Shin Young Ahn; Sejoong Kim; Ho Jun Chin; Dong-Wan Chae; Ki Young Na
Journal:  J Korean Med Sci       Date:  2014-12-23       Impact factor: 2.153

5.  Left ventricular function in children and adults after renal transplantation in childhood.

Authors:  Asle Hirth; Nicola C Edwards; Gottfried Greve; Trine Tangeraas; Eva Gerdts; Kjetil Lenes; Gunnar Norgård
Journal:  Pediatr Nephrol       Date:  2012-04-17       Impact factor: 3.714

Review 6.  Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.

Authors:  Jonathan P Law; Luke Pickup; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Hum Hypertens       Date:  2022-09-22       Impact factor: 2.877

7.  Chronic kidney disease: RAAS blockade and diastolic heart failure in chronic kidney disease.

Authors:  Casper F M Franssen; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2013-03-12       Impact factor: 28.314

8.  Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction.

Authors:  Yen-Wen Liu; Chi-Ting Su; Junne-Ming Sung; Saprina P H Wang; Yu-Ru Su; Chun-Shin Yang; Liang-Miin Tsai; Jyh-Hong Chen; Wei-Chuan Tsai
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

Review 9.  Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.

Authors:  Suzan Willemsen; Jasper W L Hartog; M Rebecca Heiner-Fokkema; Dirk J van Veldhuisen; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

10.  Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects.

Authors:  Anna M Asp; Carin Wallquist; Anette Rickenlund; Britta Hylander; Stefan H Jacobson; Kenneth Caidahl; Maria J Eriksson
Journal:  Clin Physiol Funct Imaging       Date:  2014-04-21       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.